Insider trade

Vertex Pharmaceuticals (VRTX): Officer sold ~$633K

Kristen Ambrose, Officer at Vertex Pharmaceuticals, sold ~$633K of Vertex Pharmaceuticals shares.

~$633K
Approx. value · 1,376 sh @ $459.83
9,953
Holds after · shares reported
Traded
Feb 11, 2025
Filed
Feb 12, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 13, 2024FDAFDA drug approval: Orkambi
  2. Dec 13, 2024FDAFDA drug approval: Orkambi
  3. Dec 20, 2024FDAFDA drug approval: Alyftrek
  4. Dec 20, 2024FDAFDA drug approval: Trikafta (Copackaged)
  5. Dec 20, 2024FDAFDA drug approval: Trikafta (Copackaged)
  6. Jan 30, 2025FDAFDA drug approval: Journavx
  7. Feb 11, 2025 · this disclosureInsiderOfficer sold ~$633K of VRTX shares in the open market

What came next

  1. Feb 11, 2025Insider · 3 peopleInsiders: 3 sales (~$2.5M)
  2. Feb 18, 2025Insider · 3 peopleInsiders: 3 sales (~$1.2M)
  3. Feb 20, 2025InsiderOfficer sold ~$533K of VRTX shares in the open market
  4. Feb 24, 2025CongressDisclosed purchase of VRTX — reported range $15,001 - $50,000
  5. Feb 25, 2025Insider · 4 peopleInsiders: 4 sales (~$1.9M)
  6. Feb 27, 2025Insider · 3 peopleInsiders: 3 sales (~$2.1M)
  7. Mar 3, 2025InsiderOfficer sold ~$1.58M of VRTX shares in the open market
  8. Mar 4, 2025InsiderOfficer sold ~$1.97M of VRTX shares in the open market
  9. Mar 10, 2025Insider · 3 peopleInsiders: 3 sales (~$4.9M)
  10. Mar 13, 2025InsiderOfficer sold ~$1.65M of VRTX shares in the open market
  11. Mar 13, 2025CongressDisclosed purchase of VRTX — reported range $15,001 - $50,000
  12. Mar 20, 2025Congress · 1 personMembers of Congress: 2 sales
  13. May 2, 2025InsiderDirector sold ~$202K of VRTX shares in the open market
  14. May 15, 2025InsiderOfficer sold ~$22K of VRTX shares in the open market
  15. May 22, 2025FDAFDA drug approval: Kalydeco
  16. May 22, 2025FDAFDA drug approval: Kalydeco
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

Other recent filings by Kristen Ambrose, SVP & Chief Accounting Officer

The full history of Kristen Ambrose, SVP & Chief Accounting Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Vertex Pharmaceuticals (VRTX) insider traded, and how much?

Kristen Ambrose, Officer at Vertex Pharmaceuticals, sold ~$633K of Vertex Pharmaceuticals shares. 1,376 shares at $459.83.

When did it happen, and when was it made public?

Traded: Feb 11, 2025. Filed: Feb 12, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Vertex Pharmaceuticals recently?

For Vertex Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the VRTX page.

Does this mean VRTX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Vertex Pharmaceuticals

Everything OQRO holds on this company is on its VRTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data